Form 8-K - Current report:
SEC Accession No. 0001070081-23-000059
Filing Date
2023-10-19
Accepted
2023-10-19 16:15:32
Documents
12
Period of Report
2023-10-19
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20231019x8k.htm   iXBRL 8-K 42086
  Complete submission text file 0001070081-23-000059.txt   158251

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20231019.xsd EX-101.SCH 3127
3 EX-101.LAB tmb-20231019_lab.xml EX-101.LAB 15269
4 EX-101.PRE tmb-20231019_pre.xml EX-101.PRE 9660
6 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231019x8k_htm.xml XML 4721
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 231334886
SIC: 2834 Pharmaceutical Preparations